Primary Cardiac Sarcoma: A Rare, Aggressive Malignancy with a High Propensity for Brain Metastases

Figure 3

Overall Survival of cardiac sarcoma patients (). Overall survival was significantly improved with surgical resection of PCS (a) and chemotherapy administration (b). For all patients (c), median overall survival was 12.1 months (range 0–79 months). The dashed curve represents surgery or chemotherapy and solid curve no intervention.

(a)

(b)

(c)